Cannabimimetic indole derivatives
CA 2387138 A1 · Owner: University Of Connecticut · Inventors: Deng, Hongfeng; Makriyannis, Alexandros
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel cannabimimetic indole derivatives are presented which have preferentially high affinities for one of the cannabinoid CB1 or CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain glaucoma, epilepsy, nausea associated with chemotherapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.